Purpose/Objective (s) The management of relapsed/refractory pediatric Hodgkin lymphoma
(rrpHL) is complex. Clear indications do not exist for consolidative radiotherapy (CRT), and …

Results Overall, 20 pediatric oncologist (83%) and 4 radiation oncologist (17%) members of
the COG Hodgkin Lymphoma committee completed the survey. The median reported …

Purpose/Objective (s) Doxorubicin/hydroxydaunorubicin, bleomycin, vinblastine and
dacarbazine (ABVD) chemotherapy with or without radiotherapy (RT) is widely used for the …

Background and purpose The use of radiotherapy (RT) for pediatric patients with Hodgkin
lymphoma (HL) experiencing disease progression or recurrence (15%) is controversial. We …

This multi-centric prospective study (InPOG-HL-15-01) assessed epidemiological, clinical
and outcome data of advanced stage Hodgkin Lymphoma (IIB, III and IV) in children and …

Hodgkin lymphoma (HL) is one of the most curable pediatric and adult cancers, with long-
term survival rates now exceeding 90% after treatment with chemotherapy alone or …

Hodgkin lymphoma (HL) is the most common malignancy affecting adolescents and young
adults. Treatment with a combination of chemotherapy and radiation results in cure rates of> …

TO THE EDITOR: Dörffel et al1 recently reported results from the nonrandomized phase II
German Society of Pediatric Oncology and Hematology–Hodgkin's Disease 95 (GPOH …

Purpose To minimize the risk of late effects in pediatric Hodgkin lymphoma (HL) by omitting
radiotherapy (RT) in patients in complete remission (CR) after chemotherapy and reducing …

Purpose/Objective (s) Contemporary trials in pediatric Hodgkin lymphoma (cHL) evaluate
strategies to reduce radiotherapy (RT) utilization while maintaining excellent progression …